Moreover, through a series of elegant in vitro and in vivo experiments involving isotopic labeling and flux analyses, the authors clearly demonstrate how ChREBP rewires glucose metabolism toward glycolysis and de novo lipogenesis, and also targets glucose and glutamine to feed the PPP pathway and pyrimidine synthesis in the context of cancer cells (Fig. 1). The gene discussed is MLXIPL; the disease is cancer.